Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04509765 · ClinicalTrials.gov registry record · NA
A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT04509765 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 36 participants.
The verdict
NCT04509765, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
Single institution study of safety of linac based VMAT TBI for myeloablative treatment in hematologic malignancies.
Interventions
- RADIATION Linac Based VMAT TBI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2020-09-22 |
| Est. Completion | 2025-02-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04509765
The ClinicalTrials.gov registry entry for NCT04509765 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Linac Based VMAT TBI is the first listed.
NCT04509765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04509765 about?
NCT04509765 is a clinical study titled "A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT". Single institution study of safety of linac based VMAT TBI for myeloablative treatment in hematologic malignancies.
What is the current status of trial NCT04509765?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2020-09-22. Estimated completion is 2025-02-11.
What interventions are being tested in trial NCT04509765?
The interventions under investigation include: Linac Based VMAT TBI (RADIATION).
Who is sponsoring clinical trial NCT04509765?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.